Eligible Nominees include individuals, teams of researchers, or research institutions and are nominated solely for the scientific merit of their work. Although preference is given to scientific breakthroughs with direct or obvious clinical applications, all major accomplishments in type 1 or type 2 research are considered by the Selection Jury. Employees of for-profit pharmaceutical or biotechnology companies are not eligible.
Nominations for the Prize are made by members of the Selection Jury and are therefore not open to application. However, Letters of Recommendation for Nominations will be accepted to afford the community at large an opportunity to suggest Nominees for the Prize to the Selection Jury.
Letters of Recommendation for Nominations are provided to the Jurors for consideration. Jurors may review these Letters at their discretion. Any person writing a Letter of Recommendation for Nomination is requested not to make direct contact with Jurors for the purpose of soliciting a recommendation for nominations or selection.
Letters must not exceed 1,000 words. Letters are confidential and only made available to members of the Selection Jury.
The deadline for the Open Call Letters of Recommendation is June 15, 2020. Please email letters to HammPrize@ouhsc.edu
Selection Jury members are appointed by Harold Hamm Diabetes Center representatives with priority given to individuals who have served in international capacities in the field of diabetes research such as editors of major diabetes journals or recent leaders of major diabetes-related organizations.
TSET Health Promotion Research Center at OU Health Stephenson Cancer Center and Freedom Oklahoma, a statewide LGBTQ2S+ serving organization, are ...
Oklahoma Children’s Hospital OU Health is making it more convenient for high risk pregnant women and children to receive specialty care. Oklahoma ...
Blue Cross and Blue Shield of Oklahoma (BCBSOK) and OU Health, are pleased to announce that they have signed a new agreement that champions a positive ...